GEBCX
Price
$11.81
Change
+$0.04 (+0.34%)
Updated
Sep 12 closing price
Net Assets
25.16M
VEMRX
Price
$112.26
Change
+$0.24 (+0.21%)
Updated
Sep 12 closing price
Net Assets
130.49B
Interact to see
Advertisement

GEBCX vs VEMRX

Header iconGEBCX vs VEMRX Comparison
Open Charts GEBCX vs VEMRXBanner chart's image
Goldman Sachs ESG Em Mkts Eq C
Price$11.81
Change+$0.04 (+0.34%)
VolumeN/A
Net Assets25.16M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$112.26
Change+$0.24 (+0.21%)
VolumeN/A
Net Assets130.49B
GEBCX vs VEMRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GEBCX vs. VEMRX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEBCX is a Buy and VEMRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 130B vs. GEBCX (25.2M). VEMRX pays higher dividends than GEBCX: VEMRX (2.70) vs GEBCX (0.05). GEBCX was incepted earlier than VEMRX: GEBCX (7 years) vs VEMRX (15 years). GEBCX (3.85) is less costly to investors than VEMRX (0.07). GEBCX is a more actively managed with annual turnover of: 34.00 vs. VEMRX (8.00). GEBCX has a lower initial minimum investment than VEMRX: GEBCX (1000) vs VEMRX (100000000). VEMRX annual gain was more profitable for investors over the last year : 22.98 vs. GEBCX (20.57). VEMRX return over 5 years is better than : 35.35 vs. GEBCX (6.22).
GEBCXVEMRXGEBCX / VEMRX
Total Expense Ratio2.120.073,029%
Annual Report Gross Expense Ratio3.850.075,500%
Fund Existence7 years15 years-
Gain YTD22.63821.018108%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.2M130B0%
Annual Yield % from dividends0.052.702%
Returns for 1 year20.5722.9890%
Returns for 3 years33.8841.4382%
Returns for 5 years6.2235.3518%
Returns for 10 yearsN/A84.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR48.681.48
+3.14%
Nektar Therapeutics
MCY79.360.33
+0.42%
Mercury General Corp
CRIS1.82N/A
N/A
Curis
AMP497.08-3.89
-0.78%
Ameriprise Financial
CXDO6.77-0.08
-1.17%
Crexendo